North America Intraocular Lens Market to Reach US$ 2.38 Billion by 2033, Driven by Aging Population and Technological Advancements

Aman Renub

Jul 17, 2025 - 11:19

Rising Prevalence of Cataracts and Refractive Disorders Fuels Market Growth Across the Region

According to the latest report published by Renub Research, the North America Intraocular Lens Market was valued at US$ 1.53 Billion in 2024 and is projected to reach US$ 2.38 Billion by 2033, growing at a CAGR of 5.00% from 2025 to 2033. The market is experiencing steady growth due to the increasing geriatric population, growing incidence of cataract surgeries, and the adoption of premium intraocular lenses (IOLs) enabled by innovative technologies.

? Explore the Full Report Here: North America Intraocular Lens Market Forecast 2025–2033

Expanding Need for Vision Correction in Aging Populations

Cataracts remain the leading cause of blindness worldwide, and North America is witnessing an escalating number of cataract cases due to an aging population. According to the U.S. Census Bureau, by 2030, more than 20% of the U.S. population will be aged 65 or older, significantly increasing the demand for IOL implantation procedures.

Intraocular lenses are synthetic lenses surgically implanted to replace the eye’s natural lens after cataract removal or to correct refractive errors such as myopia and astigmatism. These lenses are now widely available in monofocal, multifocal, toric, and accommodating variants, providing patients with tailored visual correction options.

Key Market Growth Drivers

1. Rising Prevalence of Cataracts and Vision Impairments

Cataracts affect over 24 million Americans aged 40 and older, and that number is projected to grow steadily. Similarly, age-related vision problems, including presbyopia and glaucoma, are contributing to a rising demand for surgical vision correction using intraocular lenses.

2. Technological Advancements in Lens Design

IOL technology has advanced rapidly in recent years, offering enhanced visual outcomes, reduced dependency on glasses, and better adaptability for patients with comorbid conditions. Innovations include:

Extended Depth-of-Focus (EDOF) lenses
Aspheric IOLs
Light-adjustable lenses (LALs)
Blue light filtering and UV-protective coatings

Such developments are attracting both ophthalmic surgeons and patients seeking improved post-surgical outcomes.

3. Shift Toward Premium IOLs

As consumers become more informed and willing to invest in their health, there is rising demand for premium intraocular lenses such as multifocal and toric IOLs. These lenses address multiple vision problems simultaneously and often eliminate the need for glasses post-surgery. This trend is particularly strong in private healthcare settings and among the senior urban population.

4. Growing Access to Eye Care Services

Improved access to eye care, expanding healthcare insurance coverage, and the rise of ambulatory surgery centers are facilitating a higher number of cataract procedures across North America. Government initiatives and awareness campaigns by organizations like Prevent Blindness and the American Academy of Ophthalmology have also played a role in early detection and treatment adoption.

Market Segmentation Insights

By Product Type:

Monofocal IOLs: Continue to dominate due to affordability and widespread usage in standard cataract procedures.
Multifocal IOLs: Gaining momentum due to their ability to provide clear vision at multiple distances.
Toric IOLs: Widely used for patients with astigmatism, offering improved refractive precision.
Accommodative IOLs: Designed to mimic the eye’s natural focusing ability, albeit still a niche segment.

By Material:

Hydrophobic Acrylic: Most preferred due to high biocompatibility and minimal postoperative complications.
Hydrophilic Acrylic: Used in budget-friendly or high-volume settings.
Silicone and PMMA: Gradually declining due to advancements in acrylic-based lenses.

By End User:

Hospitals remain the largest segment for IOL procedures, benefiting from integrated care delivery.
Ambulatory Surgical Centers (ASCs) are growing rapidly due to cost efficiency and quicker recovery times.
Ophthalmic Clinics and Specialty Centers are adopting newer IOL technologies for specialized and premium clientele.

Country-Level Analysis

United States:

The U.S. dominates the North American intraocular lens market, accounting for the largest share in both volume and revenue.
Medicare covers a significant portion of standard cataract surgeries, boosting procedural volumes.
High consumer awareness and availability of advanced lens technologies further drive growth.

Canada:

Rising elderly population and government-funded eye health programs are pushing market expansion.
Increasing acceptance of private IOL options and elective procedures is supporting the shift to premium lens types.

Key Players Shaping the North America Intraocular Lens Market

Several global and regional companies are investing in R&D, surgical training, and product development to capture a greater market share. Strategic partnerships, product launches, and regulatory approvals are key focus areas.

Leading Companies Include:

Alcon Inc.
Johnson & Johnson Vision (Abbott Medical Optics)
Carl Zeiss Meditec AG
Bausch + Lomb (Bausch Health Companies Inc.)
Hoya Corporation
Rayner Intraocular Lenses Limited
STAAR Surgical Company
HumanOptics AG

These companies are focusing on next-generation IOLs, advanced surgical tools, and ophthalmologist education programs to solidify their presence in North America.

Challenges and Market Constraints

While the outlook remains strong, the market does face a few challenges:

High cost of premium IOLs, often not fully reimbursed by insurance.
Surgical complications and patient hesitancy for elective procedures.
Regulatory approvals and clinical trial requirements can delay new product introductions.

However, these challenges are being addressed through patient education, bundled reimbursement models, and surgeon training initiatives.

Future Outlook: Innovation and Customization Will Define Market Growth

The North America Intraocular Lens Market is poised for continued innovation. The future will see:

Broader adoption of customized lens solutions for patient-specific needs.
Digital integration with surgical planning software for better lens selection.
Wider acceptance of light-adjustable IOLs, enabling post-surgery customization.

Moreover, as teleophthalmology and AI play a growing role in pre-surgical diagnostics and postoperative monitoring, intraocular lens procedures will become more precise, affordable, and accessible.

New Publish Report:

About Renub Research

Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture. Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.

Media Contact:

Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: [email protected]
Website: www.renub.com

? Read the Full Report Here: North America Intraocular Lens Market Forecast 2025–2033